FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079402 [Registered on: 24/01/2025] Trial Registered Prospectively
Last Modified On: 20/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Comparative study of Vatsadanyadi kwatha and Patoladi kwatha for Gout. 
Scientific Title of Study   Comparative clinical study to evaluate the efficacy of vatsadanyadi kwatha and patoladi kwatha in the management of vatarakta with special reference to Gout. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrNisha Amrutrao Dhotre  
Designation  PG scholar Kayachikitsa Department  
Affiliation  Shree Saptshrungi Ayurved Mahavidyalaya and hospital Kamalnagar Hirawadi Panchavati Nashik  
Address  OPD no 2 Kayachikitsa Department ground floor shree saptshrungi ayurved Mahavidyalaya Kamalnagar Hirawadi panchavati Nashik

Nashik
MAHARASHTRA
422003
India 
Phone  8600431589  
Fax    
Email  drdhotrenisha@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Somdatta Bhaskarrao Kulkarni  
Designation  HOD of Kayachikitsa Department  
Affiliation  Shree Saptshrungi Ayurved Mahavidyalaya and hospital Kamalnagar Hirawadi Panchavati Nashik  
Address  OPD no 2 Kayachikitsa Department ground floor shree saptshrungi ayurved Mahavidyalaya Kamalnagar Hirawadi panchavati Nashik Maharashtra

Nashik
MAHARASHTRA
422003
India 
Phone  9860268117  
Fax    
Email  somdattak85@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Somdatta Bhaskarrao Kulkarni  
Designation  HOD 
Affiliation  Shree Saptshrungi Ayurved Mahavidyalaya and hospital Kamal nagar Hirawadi panchavati nashik  
Address  OPD no 2 Kayachikitsa Department ground floor shree saptshrungi ayurved Mahavidyalaya Kamalnagar Hirawadi panchavati Nashik

Nashik
MAHARASHTRA
422003
India 
Phone  9860268117  
Fax    
Email  somdattaak85@gmail.com  
 
Source of Monetary or Material Support  
Shree saptashrungi Ayurved medical College and hospital,Kamal nagar,Hirawadi,panchavati,Nashik Maharashtra 422003 
 
Primary Sponsor  
Name  Shree saptshrungi Ayurved Mahavidyalaya,Kamal nagar,Hirawadi,Panchavati,Nashik 
Address  Department of Kayachikitsa,shree saptshrungi Ayurved Mahavidyalaya,Kamal nagar,Hirawadi,panchavati,Nashik Maharashtra 420003 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nisha Amrutrao Dhotre   Shree Saptshrungi Ayurved Mahavidyalaya and hospital Kamalnagar Hirawadi Panchavati Nashik   OPD no 2 Kayachikitsa Department ground floor shree saptshrungi ayurved Mahavidyalaya Kamalnagar Hirawadi panchavati Nashik
Nashik
MAHARASHTRA 
8600431589

drdhotrenisha@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC of Shree Saptshrungi Ayurved Mahavidyalaya and hospital Kamalnagar Hirawadi panchavati nashik   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M109||Gout, unspecified. Ayurveda Condition: VATARAKTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Vatsadanyadi kwatha , Reference: Bharat bhaishajya Ratnakar , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Patoladi kwatha , Reference: Yogratnakar samhita , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients will be selected irrespective of their sex religion geographical areas and economical conditions

Patients have fulfilling criteria for vatarakta such as Sandhishul a Sandhisotha Sandhigraha kandu Sandhidaha

Age group 20 to 60 years

Patients having uric acid level greater than 7 mg per dl in male and greater tha 6 mg per dl in female

Newly diagnosed cases of vatarakta  
 
ExclusionCriteria 
Details  1.Amavata (Rheumatoid Arthritis)
2. Sandhigatavata
3. With H/o Tuberculosis, malignancy, HIV, Trauma, Cardiac disease, Neurological disorders etc., associated with gout.
4. patient carring pregnancy and lactating mother.
5.patient having known complications of gout.
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduce the signs and symptoms of vatarakta   15 days 
 
Secondary Outcome  
Outcome  TimePoints 
No recurrence of vatarakta   30 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Primary Objective:
To compare the efficacy of Vatsadanyadi kwatha and Patoladi kwatha in Vatarakta with special reference to Gout.


Secondary Objectives:
1. To study the disease Vatarakta in Detail According to Ayurveda.
2. To Study Gout in Detail.
3. To Study the efficacy of Vatsadanyadi kwatha in Gout with special reference to Gout.
4. To Study the efficacy of Padoladi kwatha in Gout with special reference to Gout.

Participant 

60 Adult diagnosed with vatarakta meeting inclusion and exclusion criteria from OPD and IPD of Shree Saptshrungi Ayurved Mahavidyalaya and hospital Kamalnagar Hirawadi Panchavati Nashik 

Interventions 

30 patient Vatsadanyadi kwatha: administered according to standardized protocol.
30 patient Patoladi kwatha: administered according to standardized protocol.

Primary Outcomes:
Reduce signs and symptoms of Vatarakta 

Secondary outcomes: 
No recurrency of vatarakta 

Treatment Duration: 30days 

Follow up: 0th, 15th, 30th days 

Data analysis: 
Data will be analysed using appropriate statistical method to compare the effectiveness of the intervention on the primary and secondary outcomes 

Ethical considerations:
The study will be conducted in accordance with ethical guidelines and with informed consent from participants 
 
Close